# Post-marketing Surveillance Study With MicardisPlus® in Treatment of Morning Hypertension (Self-monitored by Patient)

> **NCT02243566** · — · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 2707 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** MicardisPlus®

## Key facts

- **NCT ID:** NCT02243566
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** 2007-01
- **Final completion:** —
- **Target enrollment:** 2707 (ACTUAL)
- **Last updated:** 2014-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02243566

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02243566, "Post-marketing Surveillance Study With MicardisPlus® in Treatment of Morning Hypertension (Self-monitored by Patient)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02243566. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*